Evaxion Biotech AS (EVAX)
3.91
-0.26
(-6.24%)
USD |
NASDAQ |
May 01, 16:00
4.05
+0.14
(+3.58%)
Pre-Market: 20:00
Evaxion Biotech Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
September 29, 2023 | 9.090 |
September 28, 2023 | 9.275 |
September 27, 2023 | 9.155 |
September 26, 2023 | 8.620 |
September 25, 2023 | 8.057 |
September 22, 2023 | 8.366 |
September 21, 2023 | 8.181 |
September 20, 2023 | 7.418 |
September 19, 2023 | 5.236 |
September 18, 2023 | 6.524 |
September 15, 2023 | 8.204 |
September 14, 2023 | 7.964 |
September 13, 2023 | 8.181 |
September 12, 2023 | 8.582 |
September 11, 2023 | 8.521 |
September 08, 2023 | 7.434 |
September 07, 2023 | 7.756 |
September 06, 2023 | 8.450 |
September 05, 2023 | 8.723 |
September 01, 2023 | 8.848 |
August 31, 2023 | 9.055 |
August 30, 2023 | 9.272 |
August 29, 2023 | 9.786 |
August 28, 2023 | 9.600 |
August 25, 2023 | 9.818 |
Date | Value |
---|---|
August 24, 2023 | 10.32 |
August 23, 2023 | 10.69 |
August 22, 2023 | 10.69 |
August 21, 2023 | 10.53 |
August 18, 2023 | 10.04 |
August 17, 2023 | 10.91 |
August 16, 2023 | 11.02 |
August 15, 2023 | 11.05 |
August 14, 2023 | 11.24 |
August 11, 2023 | 11.56 |
August 10, 2023 | 11.53 |
August 09, 2023 | 11.23 |
August 08, 2023 | 10.69 |
August 07, 2023 | 10.90 |
August 04, 2023 | 12.98 |
August 03, 2023 | 13.41 |
August 02, 2023 | 13.41 |
August 01, 2023 | 13.74 |
July 31, 2023 | 13.52 |
July 28, 2023 | 13.85 |
July 27, 2023 | 13.41 |
July 26, 2023 | 13.52 |
July 25, 2023 | 13.63 |
July 24, 2023 | 13.74 |
July 21, 2023 | 13.52 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.410
Minimum
Jun 17 2022
27.14
Maximum
Feb 08 2021
6.274
Average
4.765
Median
Jun 03 2021
Price to Book Value Benchmarks
Ascendis Pharma A/S | -- |
DBV Technologies SA | 0.9126 |
Cellectis SA | 2.154 |
Adaptimmune Therapeutics PLC | 7.496 |
Akari Therapeutics PLC | -- |
Price to Book Value Related Metrics
Price | 3.91 |
Earnings Yield | -207.2% |
Market Cap | 20.39M |